http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101767260-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-314 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-308 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 |
| filingDate | 2015-12-22^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-08-10^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-08-10^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101767260-B1 |
| titleOfInvention | Pyrimido oxazine derivatives or pharmaceutically acceptable salts thereof, preparation method thereof and pharmaceutical composition for use in preventing or treating PI3 kinase related diseases |
| abstract | The present invention relates to a pyrimidooxazine derivative or a pharmaceutically acceptable salt thereof, a process for preparing the same, and a pharmaceutical composition for preventing or treating PI3 kinase-related diseases containing the same as an active ingredient. The pyrimidooxazine derivatives according to the present invention are excellent in the selective inhibition effect on PI3 kinase, and thus can be used for the treatment of blood cancer, ovarian cancer, cervical cancer, breast cancer, colon cancer, liver cancer, gastric cancer, pancreatic cancer, colon cancer, Wherein the disease is selected from the group consisting of cancer such as cancer, bladder cancer, prostate cancer, lung cancer, osteosarcoma, fibrotic tumor, brain tumor, rheumatoid arthritis, systemic lupus erythematosis, multiple sclerosis, type 1 diabetes, hyperthyroidism, myasthenia, Chronic obstructive pulmonary disease, chronic pulmonary inflammatory disease, silicosis, pulmonary sarcoidosis, pleurisy, alveolitis, vasculitis, pneumonia, autoimmune diseases such as autoimmune diseases such as immune malignant anemia, Sjogren's syndrome, COPD, rhinitis, asthma, Inflammatory diseases such as bronchopneumonia, and respiratory diseases such as bronchiectasis. |
| priorityDate | 2015-12-22^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 305 of 305.